Security Snapshot

CareDx, Inc. - Common Stock (CDNA) Institutional Ownership

CUSIP: 14167L103

13F Institutional Holders and Ownership History from Q3 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

198

Shares (Excl. Options)

52,162,418

Price

$18.84

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Stock
Symbol
CDNA on Nasdaq
Shares outstanding
51,778,746
Price per share
$17.36
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
52,162,418
Total reported value
$982,743,810
% of total 13F portfolios
0%
Share change
-1,152,814
Value change
-$16,607,136
Number of holders
198
Price from insider filings
$17.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • CDNA - CareDx, Inc. - Common Stock is tracked under CUSIP 14167L103.
  • 198 institutions reported positions in Q4 2025.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 198 to 57 between Q4 2025 and Q1 2026.
  • Reported value moved from $982,743,810 to $167,405,649.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 198 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 14167L103?
CUSIP 14167L103 identifies CDNA - CareDx, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of CareDx, Inc. - Common Stock (CDNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8% $80,067,954 4,416,324 BlackRock, Inc. 31 Mar 2025
BAMCO INC /NY/ 5.9% $45,876,317 3,155,180 Baron Capital Group, Inc. 30 Sep 2025
GAGNON SECURITIES LLC 5.9% +14% $58,471,666 +$3,070,152 3,054,946 +5.5% Neil Gagnon 31 Dec 2025
STATE STREET CORP 5.3% $52,400,573 2,737,752 STATE STREET CORPORATION 31 Dec 2025
ARK Investment Management LLC 4.5% -20% $43,676,965 -$10,506,299 2,409,099 -19% ARK Investment Management LLC 31 Dec 2024

As of 31 Dec 2025, 198 institutional investors reported holding 52,162,418 shares of CareDx, Inc. - Common Stock (CDNA). This represents 101% of the company’s total 51,778,746 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CareDx, Inc. - Common Stock (CDNA) together control 73% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9% 4,650,409 -2.4% 0% $87,613,706
VANGUARD GROUP INC 6.6% 3,428,252 -8.6% 0% $64,588,269
BAMCO INC /NY/ 6.1% 3,155,180 0% 0.16% $59,443,591
STATE STREET CORP 5.3% 2,737,752 +6.7% 0% $51,579,248
DEERFIELD MANAGEMENT COMPANY, L.P. 4.2% 2,191,000 0% 0.53% $41,278,440
ARK Investment Management LLC 4.1% 2,136,403 -1.6% 0.27% $40,249,829
GAGNON SECURITIES LLC 3.4% 1,774,890 +2.6% 6.8% $33,438,936
BRAIDWELL LP 3.1% 1,585,220 -27% 0.96% $29,865,545
Amova Asset Management Americas, Inc. 2.8% 1,446,616 -17% 0.31% $27,254,245
Sumitomo Mitsui Trust Group, Inc. 2.8% 1,446,616 -17% 0.02% $27,254,245
DIMENSIONAL FUND ADVISORS LP 2.5% 1,309,980 +7.7% 0.01% $24,680,818
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,243,967 -4.1% 0% $23,440,229
RENAISSANCE TECHNOLOGIES LLC 2.1% 1,105,198 -4.4% 0.03% $20,821,930
Chevy Chase Trust Holdings, LLC 2.1% 1,081,342 +45% 0.06% $20,372,484
D. E. Shaw & Co., Inc. 2% 1,038,486 +75% 0.01% $19,565,076
JACOBS LEVY EQUITY MANAGEMENT, INC 1.8% 948,557 +35% 0.07% $17,870,814
Ophir Asset Management Pty Ltd 1.8% 925,433 -58% 2% $17,435,158
Boston Partners 1.7% 901,929 +2777% 0.02% $16,994,213
GOLDMAN SACHS GROUP INC 1.6% 811,186 -5.9% 0% $15,282,744
Portolan Capital Management, LLC 1.5% 758,775 -19% 0.77% $14,295,321
ArrowMark Colorado Holdings LLC 1.5% 758,400 -22% 0.31% $14,288,256
Zweig-DiMenna Associates LLC 1.3% 679,000 +18% 0.91% $12,792,360
Connor, Clark & Lunn Investment Management Ltd. 1.3% 665,065 -38% 0.03% $12,529,825
CITADEL ADVISORS LLC 1.2% 642,762 +3% 0.01% $12,109,636
ROYCE & ASSOCIATES LP 1.1% 581,211 +44% 0.11% $10,950,015

Institutional Holders of CareDx, Inc. - Common Stock (CDNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 9,644,027 $167,405,649 +$454,977 $17.36 57
2025 Q4 52,162,418 $982,743,810 -$16,607,136 $18.84 198
2025 Q3 53,545,549 $778,549,731 -$40,242,987 $14.54 183
2025 Q2 54,180,791 $1,046,039,219 -$34,127,182 $19.54 194
2025 Q1 56,024,433 $994,904,623 +$52,668,097 $17.75 217
2024 Q4 53,039,736 $1,135,520,773 +$12,398,751 $21.41 209
2024 Q3 51,572,884 $1,609,694,195 -$53,073,312 $31.22 211
2024 Q2 53,474,328 $830,399,722 -$17,416,773 $15.53 152
2024 Q1 55,046,504 $582,807,625 +$13,512,139 $10.59 145
2023 Q4 53,615,068 $643,901,906 -$8,924,782 $12.00 143
2023 Q3 55,823,102 $390,905,862 -$14,595,354 $7.00 149
2023 Q2 57,836,983 $491,678,374 -$5,229,399 $8.50 152
2023 Q1 58,175,081 $530,807,064 -$5,487,520 $9.14 153
2022 Q4 57,879,523 $660,411,212 -$10,250,992 $11.41 162
2022 Q3 56,608,841 $961,959,129 -$29,545,533 $17.02 176
2022 Q2 55,263,305 $1,201,869,454 -$25,619,576 $21.48 171
2022 Q1 56,429,741 $2,086,744,435 +$81,634,312 $36.99 203
2021 Q4 54,035,379 $2,453,632,439 -$119,982,610 $45.48 219
2021 Q3 54,551,518 $3,452,956,508 +$25,300,269 $63.37 253
2021 Q2 53,700,034 $4,913,387,108 +$230,375,047 $91.52 251
2021 Q1 52,821,421 $3,596,985,652 +$141,615,345 $68.09 242
2020 Q4 50,647,112 $3,669,710,876 +$92,822,192 $72.45 230
2020 Q3 49,717,486 $1,886,113,572 +$27,306,873 $37.94 196
2020 Q2 48,341,100 $1,712,312,049 +$180,823,082 $35.43 186
2020 Q1 44,481,052 $971,053,655 +$53,544,339 $21.83 143
2019 Q4 41,889,406 $903,491,859 +$14,908,388 $21.57 157
2019 Q3 40,724,387 $920,742,074 +$1,392,773 $22.61 172
2019 Q2 39,098,494 $1,407,144,945 +$95,766,955 $35.99 181
2019 Q1 37,465,486 $1,180,915,210 +$44,237,688 $31.52 182
2018 Q4 36,352,873 $913,810,019 +$120,230,418 $25.14 148
2018 Q3 30,160,798 $870,078,110 +$114,132,415 $28.85 138
2018 Q2 26,502,177 $324,394,223 +$104,194,989 $12.24 101
2018 Q1 18,548,133 $147,832,000 +$28,955,700 $7.97 72
2017 Q4 14,993,135 $110,045,000 +$54,709,393 $7.34 59
2017 Q3 6,614,296 $24,471,000 +$5,291,888 $3.70 25
2017 Q2 6,568,153 $7,292,000 -$23,919,006 $1.11 21
2017 Q1 7,820,767 $33,375,000 +$22,340,278 $1.40 24
2016 Q4 7,738,826 $20,894,000 -$891,239 $2.70 28
2016 Q3 8,067,061 $28,636,000 +$7,719,147 $3.55 24
2016 Q2 5,867,144 $25,273,000 +$4,077,431 $4.31 25
2016 Q1 4,897,201 $24,286,000 +$5,042 $4.96 24
2015 Q4 4,896,435 $31,337,000 +$2,567,956 $6.40 23
2015 Q3 4,495,254 $18,745,000 -$1,966,515 $4.17 22
2015 Q2 4,586,930 $29,818,000 -$4,365,504 $6.50 23
2015 Q1 5,111,041 $28,339,000 +$3,668,852 $5.54 23
2014 Q4 4,625,238 $33,495,000 +$609,569 $7.25 19
2014 Q3 5,147,963 $36,038,000 +$36,038,000 $7.00 20
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .